SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-016654
Filing Date
2017-03-15
Accepted
2017-03-15 16:45:37
Documents
6
Period of Report
2017-03-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-8331_28k.htm 8-K 37112
2 EX-99.1 a17-8331_2ex99d1.htm EX-99.1 15237
3 EX-99.2 a17-8331_2ex99d2.htm EX-99.2 97741
4 EX-99.3 a17-8331_2ex99d3.htm EX-99.3 240025
5 GRAPHIC g83312mmi001.jpg GRAPHIC 6420
6 GRAPHIC g83312mq01i001.gif GRAPHIC 4687
  Complete submission text file 0001104659-17-016654.txt   407087
Mailing Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY
Business Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37368 | Film No.: 17691788
SIC: 2836 Biological Products, (No Diagnostic Substances)